Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06854393 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lacripep for Corneal Wound Healing Study

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv6
  2. Re-verified, no change to tracked fieldsv5
  3. Study description expanded, about 3 wordsv4
  4. Eligibility criteria expanded, about 14 wordsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2025 to May 23, 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).
Trial Details
NCT Number NCT06854393
Lead Sponsor Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators: TearSolutions, Inc., Walter Reed National Military Medical Center
Conditions
(from sponsor)		 Corneal Epithelial Wound Healing
Related terms Corneal Diseases
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov